This fast-growing healthcare technology company focused on glucose monitoring may be showing signs of recovery after a difficult two years. In this analysis, we examine why investors are becoming more optimistic again, how a massive untapped global market could fuel future growth, and whether the recent share price rebound has further to run. Is it […]